| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Mmp13 ELISA Kit; Collagenase 3 ELISA Kit; EC 3.4.24.- ELISA Kit; Matrix metalloproteinase-13 ELISA Kit; MMP-13 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
matrix metalloproteinase 13 (MMP13) is a biological molecule commonly studied in cancer research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P33435
Biological context
Researchers often monitor matrix metalloproteinase 13 in serum, plasma, and tissue homogenates to better understand themes such as tumor microenvironment biology, cell proliferation and apoptosis, and metastasis and invasion pathways. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in matrix metalloproteinase 13 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cell-cycle regulators, invasion/ECM markers, and immune-oncology mediators) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, matrix metalloproteinase 13 may also appear under names such as Mmp13 and Collagenase 3. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that matrix metalloproteinase 13 participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Cuprorivaite microspheres inhibit cuproptosis and oxidative stress in osteoarthritis via Wnt/β-catenin pathway
B Li, T Jiang, J Wang, H Ge, Y Zhang, T Li, C Wang,Materials Today Bio,2024
Chondroprotective effects of Apolipoprotein D in knee osteoarthritis mice through the PI3K/AKT/mTOR signaling pathway
G Zhang,International immunopharmacology,2024
Combination of retinoids and narrow-band ultraviolet B inhibits matrix metalloproteinase 13 expression in HaCaT keratinocytes and a mouse model of psoriasis
C Xi,Scientific Reports,2021
Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
Li H,Arthritis Research & Therapy,2020
MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1B-induced chondrocyte responses
Meng F. et al,Osteoarthritis Cartilage,2016
S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro
J.T. Stefano etal,Nitric oxide-biology and chemistry,2011